Align Technology | ALGN - Nettoeinkommen

Aktienkurs
166.73
Täglich Wechseln
-5.14 -2.99%
Monatlich
-4.75%
Jährlich
15.53%
Q2 Prognose
165.46




Nettoeinkommen Veränderung Datum
3M USD 577M 257M 2025-12
Align Technology USD 135.76M 79.01M 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Bruker USD 26M 88.4M 2025-12
Cardinal Health USD 467M 17M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
CVS Health USD 2.94B 6.92B 2025-12
Danaher USD 1.2B 289M 2025-12
Dentsply International USD -146M 281M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Henry Schein USD 101M 0 2025-12
Idexx Laboratories USD 248.19M 26.42M 2025-12
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Masimo USD 68.3M 168.7M 2025-12
McKesson USD 1.19B 76M 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Solventum Corp USD 63M 1.2B 2025-12
Stryker USD 849M 10M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Veeva Systems USD 244.2M 8M 2025-12
Waters USD 225.21M 76.29M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12
Zoetis USD 603M 118M 2025-12